Agilon Health (NYSE:AGL) Hits New 52-Week High – Here’s Why

Agilon Health, Inc. (NYSE:AGL) shares hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $98.60 and last traded at $98.1610, with a volume of 129893 shares changing hands. The stock had previously closed at $95.23.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Robert W. Baird raised their price objective on shares of Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. TD Cowen reissued a “hold” rating and set a $55.00 target price (up from $17.00) on shares of Agilon Health in a research note on Monday, May 11th. Citigroup restated a “neutral” rating and issued a $80.00 price target (up from $18.75) on shares of Agilon Health in a report on Friday, May 15th. Barclays raised shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price target for the company in a research note on Tuesday, May 26th. Finally, Wells Fargo & Company reiterated an “overweight” rating and set a $72.00 price objective (up from $37.50) on shares of Agilon Health in a report on Friday, May 8th. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $58.73.

Agilon Health Price Performance

The business has a 50-day moving average price of $45.81 and a two-hundred day moving average price of $26.98. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $1.61 billion, a price-to-earnings ratio of -4.47 and a beta of 3.02.

Agilon Health (NYSE:AGL) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.38 billion. As a group, research analysts anticipate that Agilon Health, Inc. will post -3.5 EPS for the current year.

Institutional Investors Weigh In On Agilon Health

Institutional investors and hedge funds have recently made changes to their positions in the business. Goldman Sachs Group Inc. lifted its position in Agilon Health by 196.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after acquiring an additional 13,283,930 shares in the last quarter. AQR Capital Management LLC increased its holdings in Agilon Health by 1,346.6% during the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock worth $7,033,000 after purchasing an additional 9,505,837 shares in the last quarter. CenterBook Partners LP raised its stake in shares of Agilon Health by 492.4% in the third quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after purchasing an additional 9,499,012 shares during the last quarter. North Peak Capital Management LLC raised its stake in shares of Agilon Health by 10.8% in the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock worth $26,267,000 after purchasing an additional 3,715,460 shares during the last quarter. Finally, Voleon Capital Management LP lifted its holdings in shares of Agilon Health by 5,519.2% in the third quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock valued at $2,823,000 after purchasing an additional 2,692,259 shares in the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.